Cost-effectiveness of treatment of superficial basal cell carcinoma: Surgical excision vs. imiquimod 5% cream [12]

British Journal of Dermatology

Volumn 156, Issue 4, 2007, Pages 769-771

  Vanaclocha, F ^a   Dauden E ^b   Badia X ^c,d   Guillen C ^e   Conejo Mir, J S ^f   Sainz De Los Terreros, M ^g   Hamel, L ^g   Llorens, M A ^g  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d Health Outcomes Research Europe   (Spain)

^e INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

BASAL CELL CARCINOMA; BIOPSY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURGERY; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC PROCEDURE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; IMMUNE RESPONSE; LETTER; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; COST-BENEFIT ANALYSIS; HUMANS; MOHS SURGERY; SKIN NEOPLASMS;

EID: 33947421762     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07726.x     Document Type: Letter

References (8)

1. Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ 2003; 327:794-8.
2. Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004; 329:705.
3. Taylor M. Imiquimod and superficial skin cancers. J Drugs Dermatol 2005; 4:598-606.
4. Oldfield V, Keating GM, Perry CM. Imiquimod: in superficial basal cell carcinoma. Am J Clin Dermatol 2005; 6:195-202.
5. Schulze HJ, Cribier B, Requena L et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005; 152:939-47.
6. Gollnick H, Barona CG, Frank RG et al. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol 2005; 15:374-81.
7. Brosa M. Base de Datos Costes Sanitarios. Barcelona: SOIKOS, 2004.
8. Geisse J, Caro I, Lindholm J et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004; 50:722-33.